Fúster Fernández, Inés (2022)
Application of Transketolase from Geobacillus stearothermophilus for Broad Synthesis of N-Arylhydroxamates and Development of a Novel High-Throughput Reactivity Assay.
Technische Universität Darmstadt
doi: 10.26083/tuprints-00022845
Ph.D. Thesis, Primary publication, Publisher's Version
Text
Dissertation_IFF_2022.pdf Copyright Information: CC BY-SA 4.0 International - Creative Commons, Attribution ShareAlike. Download (16MB) |
Item Type: | Ph.D. Thesis | ||||
---|---|---|---|---|---|
Type of entry: | Primary publication | ||||
Title: | Application of Transketolase from Geobacillus stearothermophilus for Broad Synthesis of N-Arylhydroxamates and Development of a Novel High-Throughput Reactivity Assay | ||||
Language: | English | ||||
Referees: | Fessner, Prof. Dr. Wolf-Dieter ; Kolmar, Prof. Dr. Harald | ||||
Date: | 2022 | ||||
Place of Publication: | Darmstadt | ||||
Collation: | IX, 249 Seiten | ||||
Date of oral examination: | 24 October 2022 | ||||
DOI: | 10.26083/tuprints-00022845 | ||||
Abstract: | In nature, transketolase (TK, EC 2.2.1.1) catalyzes the reversible and stereospecific transfer of a C2-ketol moiety to the carbonyl end of a variety of aldehydes. Recently, the TK from Geobacillus stearothermophilus (TKgst) was modified by the Fessner group to accept benzaldehyde as an unnatural acceptor substrate. Because of the high electronic and structural similarity between nitrosobenzene and benzaldehyde, TKgst variants have been successfully developed and used to convert nitrosoarenes as alternative electrophilic substrates into the corresponding N-arylhydroxamic acids (HA). HAs form a class of compounds of exceptional pharmaceutical, biochemical and industrial importance; among other things, some HA possess antitumor properties. In the first chapter, a variety of para-, meta-, and ortho- mono- and disubstituted nitrosoarenes were tested using the TKgst L382N/D470S variant, which was designed for improved acceptance of benzaldehyde with hydroxypyruvate as the donor substrate. In the second chapter, a novel colorimetric endpoint assay for the screening of TKgst was developed, which is applicable in high throughput based on the ability of HA to chelate metals, such as iron(III), and it allows the determination of the HA products generated during enzymatic catalysis. In the third chapter, it was hypothesized that N-aryl-HA presumably have similar pharmacological properties to the well-known C-aryl-HA because both constitutional isomers have the ability to chelate metal ions such as iron(III) and zinc(II) in a similar way. To test this hypothesis, the readily accessible, potent HDACi N-hydroxy-4-(4-phenylbutyrylamino)benzamide (HTPB) and related N-aryl-HA were chemically synthesized. The hypothesis was confirmed by means of in vitro HDAC inhibition tests. In addition, it was shown in a laboratory proof-of-concept that HA 30, which inhibits hHDAC8 by 60 % at a concentration of 100 μM, can be prepared by TKgst-mediated catalysis. Since enzymes offer a variety of benefits, this opens up the exciting application of biocatalysts for the generation of retro-HA with biomedical properties. |
||||
Alternative Abstract: |
|
||||
Status: | Publisher's Version | ||||
URN: | urn:nbn:de:tuda-tuprints-228452 | ||||
Classification DDC: | 500 Science and mathematics > 540 Chemistry | ||||
Divisions: | 07 Department of Chemistry > Clemens-Schöpf-Institut > Organ Chemistry | ||||
Date Deposited: | 09 Nov 2022 14:06 | ||||
Last Modified: | 11 Nov 2022 07:24 | ||||
URI: | https://tuprints.ulb.tu-darmstadt.de/id/eprint/22845 | ||||
PPN: | 501431063 | ||||
Export: |
View Item |